Literature DB >> 3568943

Carbamazepine-induced acute cholangitis.

D Larrey, A Hadengue, D Pessayre, L Choudat, C DeGott, J P Benhamou.   

Abstract

We report the case of a patient with carbamazepine-induced cholestasis in whom histologic examination showed acute cholangitis. This type of lesion broadens the spectrum of carbamazepine-induced liver injury which also includes granuloma and hepatocellular necrosis. Its association with marked hypereosinophilia suggests that carbamazepine may cause acute cholangitis through an immunoallergic mechanism.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3568943     DOI： 10.1007/bf01296041

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  15 in total

1.  Chronic cholestasis following prolonged tolbutamide administration.

Authors:  D H Gregory; G F Zaki; G A Sarcosi; J B Carey
Journal:  Arch Pathol       Date:  1967-08

2.  Barbiturate jaundice. Report of a case due to a barbital-containing drug, with positive rechallenge to phenobarbital.

Authors:  L Pagliaro; G Campesi; F Aguglia
Journal:  Gastroenterology       Date:  1969-05       Impact factor: 22.682

3.  Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients.

Authors:  K G Ishak; N S Irey
Journal:  Arch Pathol       Date:  1972-04

4.  Granulomatous hepatitis associated with carbamazepine therapy.

Authors:  M C Mitchell; J K Boitnott; A Arregui; W C Maddrey
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

5.  Granulomatous hepatitis secondary to carbamazepine.

Authors:  M Levy; M W Goodman; B J Van Dyne; H W Sumner
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

6.  Granulomatous hepatitis in a patient receiving carbamazepine.

Authors:  H G Levander
Journal:  Acta Med Scand       Date:  1980

7.  [Acute hepatitis due to carbamazepine (Tegretol). Study of a case and review of the literature].

Authors:  T Davion; J P Capron; M Andrejak; P Geoffroy; D Capron-Chivrac; C Quénum
Journal:  Gastroenterol Clin Biol       Date:  1984-01

8.  Haloperidol-induced chronic cholestatic liver disease.

Authors:  H P Dincsoy; D A Saelinger
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

9.  Fatal carbamazepine-associated hepatitis. Report of two cases.

Authors:  G Hopen; I Nesthus; O D Laerum
Journal:  Acta Med Scand       Date:  1981

10.  Evaluation of prajmalium-induced cholestasis by immunologic tests.

Authors:  H H Rotmensch; A Leiser; M Dan; A Klejman; E Livni; B Ilie; G Messer; U Kadish; M Liron
Journal:  Arch Intern Med       Date:  1981-12
View more
  3 in total

Review 1.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

2.  A case of cholestatic hepatitis associated with histologic features of acute cholangitis.

Authors:  Hajime Takeuchi; Toru Kaneko; Toshikazu Otsuka; Kumiko Tahara; Tadashi Motoori; Makoto Ohbu; Masaya Oda; Hiroaki Yokomori
Journal:  Int J Gen Med       Date:  2011-11-23

3.  Dapsone induced cholangitis as a part of dapsone syndrome: a case report.

Authors:  Srivenu Itha; Ashish Kumar; Sadhna Dhingra; Gourdas Choudhuri
Journal:  BMC Gastroenterol       Date:  2003-08-11       Impact factor: 3.067
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.